OVC Research Update
Todd Duffield, David Kelton, Stephen LeBlanc, David Renaud, Charlotte Winder
OVC Research Update Todd Duffield, David Kelton, Stephen LeBlanc, - - PowerPoint PPT Presentation
OVC Research Update Todd Duffield, David Kelton, Stephen LeBlanc, David Renaud, Charlotte Winder Sampling of projects areas Managing and transporting male dairy calves Ketosis monitoring and management Knee and hock injuries
Todd Duffield, David Kelton, Stephen LeBlanc, David Renaud, Charlotte Winder
Sampling of projects areas
Navel Score Dehydration Score Source Body Weight Cough Score Sunken Flank IgG Status Cholesterol Level
Renaud et al., 2018
TREATMENT ROOM:
Selective therapy by risk
Risk: Normal Low Risk High Risk
Screening
CONTROL ROOM:
Group metaphylaxis Screening
Blanket tx Selective tx Untreated 93% (506) 91% (444) Treated 7% (38) 9% (44) Blanket tx Selective tx Survived 99% (537) 98% (477) Died 1% (7) 2% (11)
20% of calves treated
Median time to ketosis was 5 DIM (95% CI: 5 – 7 DIM) in
Median time to ketosis was 7 DIM (95% CI: 6 – 11 DIM) in milk
0.2 0.4 0.6 0.8 1 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21
Proportion of Cows with Ketosis Day of Trial
ODM TDM 0.00003% 32.2%
Once‐daily milking (ODM) more effectively resolved ketosis than twice‐daily milking (TDM) for primiparous cows
ODM heifers were more likely to resolve ketosis than TDM heifers (P<0.01)
Once‐daily milking (ODM) more effectively resolved ketosis than twice‐daily milking (TDM) for multiparous cows
0.2 0.4 0.6 0.8 1 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21
Proportion of Cows with Ketosis Day of Trial
ODM TDM 27.3% 60.3%
ODM cows were more likely to resolve ketosis than TDM cows (P<0.05)
10 20 30 40 50 60 70
1 2 3
Percentage of cows Number of additional PG treatments
ODM TDM
* Summary of data only
32 34 36 38 40 42 44 46 48 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15
Energy‐corrected milk yield (kg) Time from start of treatment (weeks)
ODM TDM
ECM is corrected for 3.5% fat & 3.2% protein (Bernard, 1997)
ODM cows produced ~25% less ECM during treatment (wk 1 & 2) (P <0.001) ODM cows produced ~14% less ECM after treatment (wk 3‐15) (P < 0.05) ODM cows produced ~6% less ECM (P=0.043)
treating ketosis and improving indicators of energy balance than treating with propylene glycol alone
Funding provided by: Dairy Farmers of Ontario OMAFRA Alliance
severity and housing environment.
transitioned to sand and pasture
Tie-stall to pasture– 7 week difference
hock and knee injuries
locomotion – lameness is also a result of the environment and other injuries (hock & knee)
(p=0.003; 95% CI: 1.4‐5.7)
lame (p=0.05; 95% CI: 1.0‐10) Implications:
score have hoof lesions.
cows to exhibit impaired locomotion.
Canada using activity meters in 2015
herd surveys to assess how well activity monitors work as tools for herd management
1400 AI on 4 farms
Leroy et al 2018
101:1638–1647
timed AI to set limits on time to 1st and repeat AI
herds
50-75 DIM, then Ovsynch
21-d pregnancy rate and economic performance to TAI-based management but this varies among herds
Denis‐Robichaud et al 2018
times, seasonally, over 1 year
data
Medrano‐Galarza et al 2018
pen
and training, growth, health
Medrano‐Galarza 2018
101:9371–9384
– Took longer to learn to use the AMF (65 vs. 30 h) – Did not increase the risk of diarrhea, but higher odds
– Decreased milk intake during the 1st week of life – Did not affect growth
– Reduce labour without affecting growth – Trade-offs between labour and calf health
~ 5 d old
26
2019 – 2021
‐ Identify calves with disease earlier ‐ Identify farms with high disease burdens
‐ E.g. pedometers, drinking aggression
27
29
Previous research has shown local anesthesia + NSAID to be best practice for paste, but no studies have examined use in calves < 7 days of age
Calves given a cornual nerve block had fewer pain behaviours
Calves given a cornual nerve block had reduced pressure sensitivity
Sham disbudded calves drank sooner following pen entry
33
f(6) aa(2) ac(1) ae(2) af(1) ag(1) ah(2) ao(2) b(1) c(4) d(4) e(1) a(2) g(3) h(2) m(2)
q(5) r(1) x(2) y(2) z(4)
Penicillin Ceftiofur x 2d Ceftiofur x 8d Penicillin/aminoglycoside Ceftiofur x 3-5d Cephaprin Cloxacillin Amoxicillin NTC
NAC(21) CLOX(15) ERY(1) GENT(1) CEPH(7) NOVO(2) PCS(2) PEN_AG(9) QUIN(2) TIL(3) TS(2) TS_CEPH(4) TS_CLOX(4) TS_CT(1) TS_PEN_AG(2) TS_TYL(1) TYL(2)
1 6 12 17 Ranking NAC(21) ERY(1) NOVO(2) TYL(2) TIL(3) CLOX(15) QUIN(2) PEN_AG(9) GENT(1) CEPH(7) 15.36(13.00, 17.00) 15.35( 5.00, 17.00) 13.69( 5.00, 17.00) 11.91( 4.00, 17.00) 11.21( 4.00, 16.00) 10.75( 6.00, 14.00) 10.11( 2.00, 16.00) 8.05( 3.00, 13.00) 7.83( 1.00, 16.00) 6.66( 2.00, 12.00)
Cephalosporin Gentamycin Penicillin/aminoglycoside Quinalones Cloxacillin Tilmicosin Tylosin Novobiocin Erythromycin Non‐active or non‐ treated control
42
Despite a large volume of research, we don’t have good data to know products’ relative efficacy In deciding whether to treat, decide on cow-factors <- most important! Which treatment to pick? <- selection should be based on other factors